NCT06192784 2024-01-09
CCGLC-012
Tongji Hospital
Phase 2 Unknown
Clinical Trials
3 trialsNCT04211168 2023-03-29
Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers
Peking Union Medical College Hospital
Phase 2 Unknown
NCT03951597 2021-07-07
Combined Therapy Using Oxaliplatin and Gemcitabine Chemotherapy, Lenvatinib and PD1 Antibody (JS001) for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital
Phase 2 Unknown